drug delivery

News

Takeda tries again with subcutaneous Entyvio

More than three years after it was first rejected by the FDA, Takeda's subcutaneous (SC) formulation of Entyvio has been resubmitted as a maintenance therapy for ulcerativ

R&D

LNPs: The unknown enabler behind mRNA vaccines

Drug delivery technologies are crucial to allow drugs to reach their full potential, and yet they rarely receive much spotlight.

R&D

Partner Content

5th Annual Injectable Drug Delivery Conference

10 – 11 May 2023 London, UK www.injectable-drug-delivery.com/PharmaPhorum-EL

News

Phase 3 trial dashes Oramed's oral insulin hopes

Oramed Pharma has conceded defeat in its attempt to bring an oral formulation of insulin to market for people with type 2 diabetes, after its ORMD-0801 candidate missed the mark in a phase

News

Restructuring announced at ReNeuron as another CEO resigns

Catherine Isted has stepped down as chief executive of UK biotech ReNeuron with immediate effect, with board member and biopharma industry veteran Iain Ross appointed as executive chairman

News

Lilly has committed $42.5 million over 10 years to fund pharmaceutical manufacturing scholarships for incoming Purdue undergraduate students, offering 75-100 talented students each year full tuition with a guaranteed internship (Purdue University photo)

Lilly deepens bonds with Purdue University with new funding ...

Eli Lilly's links to Purdue University go back a long way, and have been reinvigorated with $92.5 million in additional funding and renewed research collaborations.

Takeda tries again with subcutaneous Entyvio

LNPs: The unknown enabler behind mRNA vaccines

5th Annual Injectable Drug Delivery Conference

Phase 3 trial dashes Oramed's oral insulin hopes

Restructuring announced at ReNeuron as another CEO resigns

Lilly deepens bonds with Purdue University with new funding ...

Setback for MSD as German court blocks Keytruda SC launch

How to meet your physicians where they are online

drug delivery

Editor's Picks